Is Belle legit and worth it?
Belle is a real GLP-1 telehealth provider; we read its site and scored it 3.7/5 in our independent review (Competitive but Mixed). Biggest plus: Competitive pricing at $199-$349/mo. Watch-out: No lab testing listed.
Scorecard: strongest in Access (4.7/5) and Cost & Value (4.6/5); weakest in Authenticity (2.7/5) and Trust & Transparency (3.5/5).
Medications
Compounded Semaglutide, Compounded Tirzepatide (as listed on its site, 7 April 2026)
Monthly Cost
$199-$349/mo (as listed on its site, 7 April 2026)
Speed to Start
Fast
Prices and medications in this review are as listed on Belle’s site on 7 April 2026, unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
Est. 2022
About Belle
Belle is a GLP-1 telehealth provider founded in 2022 that offers compounded semaglutide and tirzepatide with pricing between $199 and $349 per month.
For patients who have been burned by other telehealth platforms with opaque refund policies or unresponsive support teams, this track record provides a degree of assurance that is genuinely hard to find elsewhere. Our editorial team views this as Belle’s single most important competitive advantage.
On Trustpilot, Belle carries a 4.4-star rating from 560+ reviews. The review volume is moderate but growing, and the 4.4-star score suggests a company that takes patient satisfaction seriously. Positive reviews highlight responsive customer support and clear communication about the treatment process. Negative reviews, where they exist, tend to focus on medication side effects rather than operational failures, which is a qualitatively different complaint profile than most competitors.
Belle’s clinical model provides medium-level support, including some structured follow-up and communication touchpoints beyond the initial prescription. This is not a full-service weight management program with dietitians and lab panels, but it offers more ongoing engagement than the bare-minimum providers in the market. Pricing is competitive without being the cheapest, positioning Belle in a value-oriented middle ground that balances cost, support, and accountability.
In our assessment, Belle represents one of the better risk-adjusted options in the compounded GLP-1 space. Combined with solid Trustpilot scores and reasonable pricing, Belle offers a package that should appeal to patients who have done their research and want a provider with a demonstrated commitment to resolving issues when they arise.
At a Glance
Medications Offered
Compounded Semaglutide, Compounded Tirzepatide (as listed on its site, 7 April 2026)
Compounded
Cost & Insurance
- Monthly: $199-$349/mo (as listed on its site, 7 April 2026)
- 6-month estimate: $1,194-$2,094 (as listed on its site, 7 April 2026)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: Yes: Belle lists “Weekly check-ins with registered dietitian” (its own page, read 7 October 2026) Corrected 13 October 2026: this line said “No”; the provider’s own page says otherwise. A con that repeated it has been reworded.
- Pharmacies named: Belle names pharmacies on its own pages (terms and treatments page, read 7 and 8 October 2026). With a city: BPI Labs (Largo, FL), VitalRx (Pearland, TX), Olympia Pharmaceuticals (Orlando, FL), The Pharmacy Hub (Miami, FL), and, listed as “pharmacy partners”, Hillstone Pharmacy (Knoxville, TN), Hyalo (Somerset, NJ), OptioRx (Palm Beach Gardens, FL) and NewLife Rx (Easton, PA). As product tags only: Boudreaux, ReviveRX, Apothecary Pharma, Hallandale and VialsRx. It does not say which pharmacy fills which product. FDA sent Belle Health LLC a warning letter on 20 February 2026 (letter 721795): product labels pictured on its website showed “Belle”, suggesting Belle was the compounder. Corrected 13 October 2026: this field said “Partner pharmacy not named publicly”. Belle names its pharmacies on its own pages, so the field now lists them. The warning-letter line now gives the letter’s date and number.
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not stated Corrected 13 October 2026: this line said “Not available”, but our research had recorded it as unknown.
Start your GLP-1 weight loss journey with Belle today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.
What the Belle Intake Looks Like
We walked through Belle’s intake ourselves, from the opening “Let’s get started” welcome through medical history, a named GLP-1 drug allergy screen, medication selection, and the final treatment plan with a non-refundable 6-month charge.
Solid medical history coverage. Personal-or-family MTC, pancreatitis or pancreatic cancer, gastroparesis, IBD, hypertriglyceridemia, kidney injury, 6-month bariatric recency, a named GLP-1 brand allergy screen, and a named diabetes drug interaction screen covering sulfonylureas and DPP-4 inhibitors.
Moderate. The intake is fast at ~5 minutes, but the default 6-month plan bills $1,194 up front and Belle’s checkout warns that orders cannot be canceled or refunded once processing begins. Read that line carefully.
The 8 Stages
Belle is one of the few platforms we’ve audited that asks a dedicated “Are you allergic to any of the following medications?” screen naming Ozempic, Wegovy, Zepbound, Mounjaro, and Saxenda by brand. Most intakes lean on a generic “do you have any allergies” yes/no. Belle pairs that generic gate with a specific GLP-1 brand allergy screen — clinically meaningful because a prior severe reaction to one semaglutide or tirzepatide product is a direct contraindication to compounded versions of the same molecule.
Belle’s drug interaction screen names sulfonylureas (glimepiride / Amaryl, glipizide / Glucotrol XL, glyburide / Micronase / Glynase / Diabeta) and DPP-4 inhibitors (sitagliptin, saxagliptin, linagliptin, alogliptin) in addition to insulin. That matters because GLP-1 receptor agonists combined with insulin or sulfonylureas materially increase hypoglycemia risk, and most GLP-1 intakes either ask a generic “are you on any medications” field or skip drug-interaction screening entirely. Belle handles it as a structured gate in the written flow.
The Belle treatment plan page carries an explicit warning: “Please note: Orders begin processing immediately, so once placed, they cannot be canceled or refunded.” The default 6-month plan bills $1,194 in a single charge today, dropping the monthly rate to $199 — but that’s a real lump-sum commitment, not a monthly subscription. Patients evaluating Belle should understand that picking the lowest-monthly-cost option means the refund path closes at the moment the order is placed, and that the optional MIC+B12 ($139) and NAD+ ($149) upsells are subject to the same no-refund rule.
No eating disorder screen, no pregnancy or breastfeeding screen, no validated PHQ or mental-health instrument, no substance use or alcohol screen, no self-reported blood pressure or resting heart rate, and no MEN-2 gate split out from the personal-or-family MTC question. No ID upload and no phone OTP. Belle’s strengths are concentrated in the named drug-allergy and drug-interaction screens; its clinical net is narrower than the high-rigor tier of the catalog.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of the Belle intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens joinbelle.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
